ArticlePLoS computational biology2024
Overcoming CRISPR-Cas9 off-target prediction hurdles: A novel approach with ESB rebalancing strategy and CRISPR-MCA model.
Article in PLoS computational biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Harnessing Deep Learning Models for Guide RNA Optimization and Off-Target Prediction in CRISPR Systems.Biotechnology journal · 2026Review
- Feature representation for explainable CRISPR off-target prediction and base editing efficiency.Frontiers in bioinformatics · 2026Article
- From Code to Life: The AI-Driven Revolution in Genome Editing.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Review
- Article
- Prediction of CRISPR-Cas9 on-target activity based on a hybrid neural network.Computational and structural biotechnology journal · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The off-target activities within the CRISPR-Cas9 system remains a formidable barrier to its broader application and development. Recent advancements have highlighted the potential of deep learning models in predicting these off-target effects, yet they encounter significant hurdles including imbalances within datasets and the intricacies associated with encoding schemes and model architectures. To surmount these challenges, our study innovatively introduces an Efficiency and Specificity-Based (ESB) class rebalancing strategy, specifically devised for datasets featuring mismatches-only off-target instances, marking a pioneering approach in this realm. Furthermore, through a meticulous evaluation of various One-hot encoding schemes alongside numerous hybrid neural network models, we discern that encoding and models of moderate complexity ideally balance performance and efficiency. On this foundation, we advance a novel hybrid model, the CRISPR-MCA, which capitalizes on multi-feature extraction to enhance predictive accuracy. The empirical results affirm that the ESB class rebalancing strategy surpasses five conventional methods in addressing extreme dataset imbalances, demonstrating superior efficacy and broader applicability across diverse models. Notably, the CRISPR-MCA model excels in off-target effect prediction across four distinct mismatches-only datasets and significantly outperforms contemporary state-of-the-art models in datasets comprising both mismatches and indels. In summation, the CRISPR-MCA model, coupled with the ESB rebalancing strategy, offers profound insights and a robust framework for future explorations in this field.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.